Measuring Symptom Relief After Radiofrequency Ablation of the Thyroid

Overview

About this study

The purpose of this study is to measure the impact of thyroid ablation on patient’s thyroid-related symptoms using a pre-existing scoring system.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

≥ 18 years of age.
Undergoing Radiofrequency Ablation (RFA) for symptomatic thyroid nodule(s).

Exclusion Criteria:

< 18 years of age.
Decline to participate in research.

Eligibility last updated 7/20/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Thomas Atwell, M.D.	Open for enrollment	Contact information: Desirae Howe-Clayton (507) 255-0111 Howe.Desirae@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Thomas Atwell, M.D.

Open for enrollment

Contact information:

Desirae Howe-Clayton

(507) 255-0111

Howe.Desirae@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials